Reaching for the Holy Grail of Chronic Obstructive Pulmonary Disease Outcomes. Can Medications Modify Lung Function Decline?

Am J Respir Crit Care Med. 2018 Jan 1;197(1):2-4. doi: 10.1164/rccm.201708-1549ED.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androstadienes
  • Benzyl Alcohols
  • Cardiovascular Diseases*
  • Chlorobenzenes
  • Humans
  • Pulmonary Disease, Chronic Obstructive*
  • Risk Factors

Substances

  • Androstadienes
  • Benzyl Alcohols
  • Chlorobenzenes
  • vilanterol
  • fluticasone furoate